Anzeige
Mehr »
Sonntag, 24.05.2026 - Börsentäglich über 12.000 News
Diese 0,13 €-Aktie besitzt 2 der wichtigsten kritischen Metalle der Welt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 897914 | ISIN: US23918K1088 | Ticker-Symbol: TRL
Tradegate
22.05.26 | 20:20
172,05 Euro
+0,56 % +0,95
Branche
Gesundheitswesen
Aktienmarkt
S&P 500
1-Jahres-Chart
DAVITA INC Chart 1 Jahr
5-Tage-Chart
DAVITA INC 5-Tage-Chart
RealtimeGeldBriefZeit
171,00171,7018:04
170,20171,9522.05.
ACCESS Newswire
439 Leser
Artikel bewerten:
(2)

DaVita: The Doctor Will See You Now: The Value of Human Connection in AI-Supported Medicine

As artificial intelligence (AI) continues to take hold across all industries, Adam Weinstein, MD, chief medical information officer for DaVita, highlights how new technological capabilities also help make the human connection more central to healthcare.

NORTHAMPTON, MA / ACCESS Newswire / April 7, 2026 / Recently, a New York Times article explored the question of whether advancements to AI in medicine could reduce the value of a doctor. Do you see this taking place - or is AI redefining that value?

Dr. Weinstein: I think AI changes the balance of how doctors work rather than reduces the value of that work.

Technology has always shaped and reshaped medicine. The internet changed how we access information. Electronic health records changed how we interact with data. Before that, medical textbooks and journals shaped how physicians stayed current.

Technology and times change.

AI is probably a tool that will change the nature of how physicians do their work.

The irreducible value of a physician is the coaching, the relationship and the human-to-human interaction that translates knowledge and information into suggested action.

Humans - our patients - are often inconsistent and struggle with long-term changes in behavior patterns. The role of physicians and clinicians is to provide consistent support and advice over time.

That human connection, sustained over years in complex chronic disease, is not diminished by AI

It may actually become more central.

What makes kidney care a good fit for AI tools?

Dr. Weinstein: Success in complex chronic disease management - like kidney care - requires two things: large amounts of data and long-term relationships that help shape patient outcomes.

Nephrology is extremely data rich, with information collected from a wide variety of sources - labs, dialysis metrics, blood pressures, medications, hospitalization data, imaging, specialist notes.

The challenge is not the absence of data. The challenge is fragmentation, variability in format and the cognitive load required to assemble a coherent clinical picture.

For me, the greatest promise AI in nephrology is effective summarization and aggregation to directly reduce the cognitive burden and uncover nuanced patterns that may otherwise be too subtle or too time-consuming to detect during a busy day. This provides immediate and meaningful value for clinicians and their patients.

How does this change your day as a physician?

Dr. Weinstein: If AI manages data retrieval, summarization and pattern recognition, it can fundamentally shift how I spend my time.

Much of my cognitive energy goes toward searching medical records, reconciling information across systems and interacting with a keyboard. If that burden is reduced, I can redirect that time toward coaching and education - which is central to managing chronic kidney disease.

This also has the potential to impact physician well-being. Reducing cognitive load mitigates the "drinking from a firehose" effect of information overload. It creates space not only for better patient interaction, but also for addressing burnout and mental fatigue among clinicians.

Essentially it could perhaps give more of that human role back to caregivers. More time making eye contact. More time building rapport. More time reinforcing what we know helps improve outcomes.

What is the value of human connection in medicine?

Dr. Weinstein: At least for the foreseeable future, AI struggles with the subtleties of human emotion and the ability to read between the lines. Patients often communicate indirectly: Their tone, hesitation, body language and inconsistencies all carry meaning.

There is also the matter of trust. Many patients may not fully trust technology or may lack consistent access to it. For them, the human relationship is foundational.

And, there is something powerful about human-to-human accountability. Patients sometimes adhere to treatment not because an algorithm or literature tells them to, but because they trust the person sitting across from them.

That relational bond is difficult to replicate electronically. It involves nuance, empathy, social norms and shared history.

How can healthcare systems help ensure physicians maintain decision-making authority?

Dr. Weinstein: Appropriate AI use begins with training and governance.

First, the right people need access to the right tools. Second, clinicians must understand both the capabilities and limitations of AI systems change. Medical terminology evolves. LLMs are upgraded. Data quality varies. Outputs can drift.

Healthcare systems must establish institutional safeguards - governance frameworks, audit mechanisms and clear expectations that AI remains advisory rather than determinative.

Equally important is cultivating individual accountability and critical thinking among all clinical and physician users. Clinicians and physicians must be trained to ask the right questions (what do you really want to know about this data or patient?) and view AI output from through lens of patient safety, error-checking, a broader clinical context, as well as bias or drift monitoring.

The goal is augmented decision making (enhancing the quality, speed or depth of thought while keeping the human in the loop), not an abdication of critical thinking.

Dr. Adam Weinstein Chief Medical Information Officer for DaVita

Find more stories and multimedia from DaVita at 3blmedia.com.

Contact Info:
Spokesperson: DaVita
Website: https://www.3blmedia.com/profiles/davita
Email: info@3blmedia.com

SOURCE: DaVita



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/the-doctor-will-see-you-now-the-value-of-human-connection-in-ai-suppo-1155524

© 2026 ACCESS Newswire
Vergessen Sie Gold, Silber und Öl: Nächste Megarallye startet!
Die Märkte feiern neue Rekorde – doch im Hintergrund braut sich eine Entwicklung zusammen, die alles verändern könnte. Die anhaltende Sperrung der Straße von Hormus sorgt laut IEA für eine der größten Energiekrisen aller Zeiten. Gleichzeitig schießen die Preise für Düngemittel und Agrarrohstoffe bereits nach oben.

Damit droht ein perfekter Sturm: steigende Energiepreise, explodierende Produktionskosten und ein möglicher Super-El-Nino, der weltweit Ernten gefährdet. Erste Auswirkungen sind längst sichtbar – Weizen, Soja und Kakao verteuern sich deutlich, während Lebensmittelpreise vor dem nächsten Sprung stehen könnten.

Für Anleger bedeutet das nicht nur Risiken, sondern enorme Chancen. Denn während klassische Märkte unter Druck geraten könnten, entsteht auf den Feldern und Plantagen der nächste große Rohstoffzyklus. Wer sich jetzt richtig positioniert, kann von einer Entwicklung profitieren, die weit über Öl und Metalle hinausgeht.

In unserem aktuellen Spezialreport stellen wir drei Aktien vor, die besonders aussichtsreich sind, um von diesem Trend zu profitieren – solide positioniert, strategisch relevant und mit erheblichem Aufwärtspotenzial.



Jetzt den kostenlosen Report sichern – bevor der Agrar-Boom voll durchschlägt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.